1
APPLE INC
COM
AAPL
AAPL
7,445
$2.2m2.06%
2.06%
New Shares held: Q3 2025 —, Q4 2025 4.2k, Q1 2026 0, Q2 2026 7.4k
2
BELITE BIO INC
SPONSORED ADS
BLTE
BLTE
13,758
$2.1m2.03%
2.03%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 13.8k, Q2 2026 13.8k
-55
-55
-0.4%
3
ACADIA PHARMACEUTICALS INC
COM
ACAD
ACAD
82,629
$2.1m2.00%
2.00%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 68.3k, Q2 2026 82.6k
+14.3k
+14,339
21.0%
4
COMCAST CORP NEW
CL A
CMCSA
CMCSA
84,569
$2.1m1.99%
1.99%
Added Shares held: Q3 2025 —, Q4 2025 98.4k, Q1 2026 41.5k, Q2 2026 84.6k
+43.0k
+43,020
103.5%
5
CHATHAM LODGING TR
COM
CLDT
CLDT
140,000
$1.9m1.77%
1.77%
Unchanged Shares held: Q3 2025 —, Q4 2025 115.0k, Q1 2026 140.0k, Q2 2026 140.0k
6
TENAX THERAPEUTICS INC
COM NEW
TENX
TENX
123,174
$1.8m1.72%
1.72%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 95.3k, Q2 2026 123.2k
+27.8k
+27,844
29.2%
7
SLIDE INS HLDGS INC
COM
SLDE
SLDE
91,070
$1.8m1.69%
1.69%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 30.7k, Q2 2026 91.1k
+60.4k
+60,412
197.1%
8
ZYMEWORKS INC
COM
ZYME
ZYME
66,688
$1.7m1.67%
1.67%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 82.7k, Q2 2026 66.7k
-16.0k
-16,010
-19.4%
9
AMN HEALTHCARE SVCS INC
COM
AMN
AMN
51,906
$1.7m1.61%
1.61%
Added Shares held: Q3 2025 —, Q4 2025 45.0k, Q1 2026 50.0k, Q2 2026 51.9k
+1.9k
+1,906
3.8%
10
X4 PHARMACEUTICALS INC
COM NEW
XFOR
XFOR
352,093
$1.6m1.57%
1.57%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 352.1k
11
VERSANT MEDIA GROUP INC
COM CL A
VSNT
VSNT
43,503
$1.6m1.50%
1.50%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 19.0k, Q2 2026 43.5k
+24.5k
+24,506
129.0%
12
NETSCOUT SYS INC
COM
NTCT
NTCT
33,128
$1.4m1.38%
1.38%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 14.7k, Q2 2026 33.1k
+18.4k
+18,406
125.0%
13
AADI BIOSCIENCE INC
COM
WHWK
WHWK
301,483
$1.4m1.32%
1.32%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 115.5k, Q2 2026 301.5k
+186.0k
+185,999
161.1%
14
JOHNSON & JOHNSON
COM
JNJ
JNJ
5,384
$1.4m1.31%
1.31%
Reduced Shares held: Q3 2025 —, Q4 2025 17.4k, Q1 2026 5.4k, Q2 2026 5.4k
-34
-34
-0.6%
15
CONTINEUM THERAPEUTICS INC
CL A
CTNM
CTNM
81,014
$1.3m1.27%
1.27%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 86.0k, Q2 2026 81.0k
-5.0k
-5,018
-5.8%
16
JADE BIOSCIENCES INC
COM NEW
JBIO
JBIO
56,384
$1.3m1.20%
1.20%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 56.4k
17
CISCO SYS INC
COM
CSCO
CSCO
10,307
$1.2m1.16%
1.16%
New Shares held: Q3 2025 —, Q4 2025 29.9k, Q1 2026 0, Q2 2026 10.3k
18
NURIX THERAPEUTICS INC
COM
NRIX
NRIX
49,511
$1.2m1.15%
1.15%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 83.4k, Q2 2026 49.5k
-33.9k
-33,914
-40.6%
19
PROTARA THERAPEUTICS INC
COM STK
TARA
TARA
312,249
$1.2m1.14%
1.14%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 312.2k
20
BLOOMIN BRANDS INC
COM
BLMN
BLMN
130,000
$1.2m1.14%
1.14%
Added Shares held: Q3 2025 —, Q4 2025 100.0k, Q1 2026 100.0k, Q2 2026 130.0k
+30.0k
+30,000
30.0%
21
TYRA BIOSCIENCES INC
COM
TYRA
TYRA
36,003
$1.1m1.10%
1.10%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 36.0k
22
PAR PAC HOLDINGS INC
COM NEW
PARR
PARR
20,000
$1.1m1.07%
1.07%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 22.5k, Q2 2026 20.0k
-2.5k
-2,500
-11.1%
23
EDGEWISE THERAPEUTICS INC
COM
EWTX
EWTX
27,234
$1.1m1.06%
1.06%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 13.1k, Q2 2026 27.2k
+14.2k
+14,182
108.7%
24
ALPHABET INC
CAP STK CL A
GOOGL
GOOGL
2,900
$1.0m0.99%
0.99%
New Shares held: Q3 2025 —, Q4 2025 8.5k, Q1 2026 0, Q2 2026 2.9k
25
CARTERS INC
COM
CRI
CRI
25,000
$1.0m0.99%
0.99%
Unchanged Shares held: Q3 2025 —, Q4 2025 20.0k, Q1 2026 25.0k, Q2 2026 25.0k
26
VERA THERAPEUTICS INC
CL A
VERA
VERA
23,487
$1.0m0.97%
0.97%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 10.2k, Q2 2026 23.5k
+13.3k
+13,306
130.7%
27
NUVALENT INC
COM
COM
8,104
$1.0m0.96%
0.96%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 8.1k
28
DIANTHUS THERAPEUTICS INC
COM
DNTH
DNTH
10,062
$980.8k0.94%
0.94%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 8.7k, Q2 2026 10.1k
+1.4k
+1,363
15.7%
29
ACLARIS THERAPEUTICS INC
COM
ACRS
ACRS
175,272
$927.2k0.89%
0.89%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 197.0k, Q2 2026 175.3k
-21.8k
-21,770
-11.1%
30
OPPENHEIMER HLDGS INC
CL A NON VTG
OPY
OPY
8,673
$915.3k0.88%
0.88%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 3.4k, Q2 2026 8.7k
+5.3k
+5,252
153.5%
31
VERIZON COMMUNICATIONS INC
COM
VZ
VZ
20,938
$886.5k0.85%
0.85%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 20.9k
32
MYERS INDS INC
COM
MYE
MYE
24,500
$865.1k0.83%
0.83%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 24.5k
33
ENLIVEN THERAPEUTICS INC
COM
ELVN
ELVN
16,957
$860.6k0.82%
0.82%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 17.0k
34
UNIVERSAL INS HLDGS INC
COM
UVE
UVE
20,558
$850.3k0.81%
0.81%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 20.6k
35
BANK NEW YORK MELLON CORP
COM
BNY
BNY
5,748
$831.2k0.80%
0.80%
Reduced Shares held: Q3 2025 —, Q4 2025 14.8k, Q1 2026 9.0k, Q2 2026 5.7k
-3.2k
-3,203
-35.8%
36
PC CONNECTION INC
COM
CNXN
CNXN
11,084
$809.0k0.77%
0.77%
New Shares held: Q3 2025 —, Q4 2025 8.2k, Q1 2026 0, Q2 2026 11.1k
37
AMERICAN INTEGRITY INS GROUP
COM
AII
AII
42,178
$794.2k0.76%
0.76%
Added Shares held: Q3 2025 —, Q4 2025 37.5k, Q1 2026 41.1k, Q2 2026 42.2k
+1.1k
+1,083
2.6%
38
APPLIED MATLS INC
COM
AMAT
AMAT
1,089
$787.3k0.75%
0.75%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 2.9k, Q2 2026 1.1k
-1.8k
-1,805
-62.4%
39
ADAPTHEALTH CORP
COMMON STOCK
AHCO
AHCO
75,000
$781.5k0.75%
0.75%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 95.0k, Q2 2026 75.0k
-20.0k
-20,000
-21.1%
40
ALLSTATE CORP
COM
ALL
ALL
3,279
$780.2k0.75%
0.75%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 3.3k
41
CELLDEX THERAPEUTICS INC NEW
COM NEW
CLDX
CLDX
20,704
$770.4k0.74%
0.74%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 20.7k
42
REVOLUTION MEDICINES INC
COM
RVMD
RVMD
4,053
$759.0k0.73%
0.73%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 21.6k, Q2 2026 4.1k
-17.5k
-17,519
-81.2%
43
HERITAGE INSURANCE HLDGS INC
COM
HRTG
HRTG
28,575
$745.2k0.71%
0.71%
Added Shares held: Q3 2025 —, Q4 2025 28.8k, Q1 2026 26.5k, Q2 2026 28.6k
+2.1k
+2,081
7.8%
44
TD SYNNEX CORPORATION
COM
SNX
SNX
2,780
$743.2k0.71%
0.71%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 1.4k, Q2 2026 2.8k
+1.3k
+1,334
92.2%
45
MOVADO GROUP INC
COM
MOV
MOV
18,762
$737.5k0.71%
0.71%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 10.7k, Q2 2026 18.8k
+8.0k
+8,019
74.6%
46
SMART SAND INC
COM
SND
SND
142,684
$714.8k0.68%
0.68%
Added Shares held: Q3 2025 —, Q4 2025 101.0k, Q1 2026 122.7k, Q2 2026 142.7k
+20.0k
+19,988
16.3%
47
VIRIDIAN THERAPEUTICS INC
COM
VRDN
VRDN
38,722
$711.3k0.68%
0.68%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 31.2k, Q2 2026 38.7k
+7.5k
+7,543
24.2%
48
DESIGN THERAPEUTICS INC
COM
DSGN
DSGN
47,557
$688.1k0.66%
0.66%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 92.3k, Q2 2026 47.6k
-44.8k
-44,753
-48.5%
49
MARCUS & MILLICHAP INC
COM
MMI
MMI
21,972
$684.9k0.66%
0.66%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 15.5k, Q2 2026 22.0k
+6.4k
+6,433
41.4%
50
MATIV HOLDINGS INC
COM
MATV
MATV
90,000
$681.3k0.65%
0.65%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 90.0k
51
STONEX GROUP INC
COM
SNEX
SNEX
5,682
$673.3k0.64%
0.64%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 6.9k, Q2 2026 5.7k
-1.3k
-1,265
-18.2%
52
CYTOMX THERAPEUTICS INC
COM
CTMX
CTMX
176,407
$661.5k0.63%
0.63%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 30.2k, Q2 2026 176.4k
+146.2k
+146,220
484.4%
53
NET LEASE OFFICE PROPERTIES
COM
NLOP
NLOP
58,791
$654.3k0.63%
0.63%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 23.9k, Q2 2026 58.8k
+34.9k
+34,862
145.7%
54
GERON CORP
COM
GERN
GERN
494,201
$632.6k0.61%
0.61%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 494.2k
55
OOMA INC
COM
OOMA
OOMA
32,810
$630.6k0.60%
0.60%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 19.3k, Q2 2026 32.8k
+13.5k
+13,484
69.8%
56
ROCKY BRANDS INC
COM
RCKY
RCKY
15,254
$629.1k0.60%
0.60%
Added Shares held: Q3 2025 —, Q4 2025 15.0k, Q1 2026 15.0k, Q2 2026 15.3k
+254
+254
1.7%
57
JANUX THERAPEUTICS INC
COM
JANX
JANX
40,386
$620.3k0.59%
0.59%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 40.4k
58
ZOOM COMMUNICATIONS INC
CL A
ZM
ZM
7,125
$615.0k0.59%
0.59%
Reduced Shares held: Q3 2025 —, Q4 2025 20.9k, Q1 2026 21.6k, Q2 2026 7.1k
-14.5k
-14,455
-67.0%
59
STRUCTURE THERAPEUTICS INC
SPONSORED ADS
GPCR
GPCR
11,335
$608.3k0.58%
0.58%
Unchanged Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 11.3k, Q2 2026 11.3k
60
AVALO THERAPEUTICS INC
COM NEW
AVTX
AVTX
32,827
$606.6k0.58%
0.58%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 32.8k
61
MISTRAS GROUP INC
COM
MG
MG
34,526
$603.2k0.58%
0.58%
Unchanged Shares held: Q3 2025 —, Q4 2025 50.0k, Q1 2026 34.5k, Q2 2026 34.5k
62
VIEMED HEALTHCARE INC
COM
VMD
VMD
52,879
$602.8k0.58%
0.58%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 52.9k
63
RELMADA THERAPEUTICS INC
COM
RLMD
RLMD
86,994
$602.0k0.58%
0.58%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 47.1k, Q2 2026 87.0k
+39.8k
+39,845
84.5%
64
CLIMB BIO INC
COM
CLYM
CLYM
46,115
$601.3k0.58%
0.58%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 144.5k, Q2 2026 46.1k
-98.4k
-98,425
-68.1%
65
CORBUS PHARMACEUTICALS HLDGS
COM NEW
CRBP
CRBP
63,603
$596.6k0.57%
0.57%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 50.3k, Q2 2026 63.6k
+13.4k
+13,351
26.6%
66
BRISTOL-MYERS SQUIBB CO
COM
BMY
BMY
10,263
$591.4k0.57%
0.57%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 10.3k
67
SECURITY NATL FINL CORP
CL A NEW
SNFCA
SNFCA
60,000
$581.4k0.56%
0.56%
Unchanged Shares held: Q3 2025 —, Q4 2025 80.8k, Q1 2026 60.0k, Q2 2026 60.0k
68
USANA HEALTH SCIENCES INC
COM
USNA
USNA
26,068
$556.6k0.53%
0.53%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 17.1k, Q2 2026 26.1k
+9.0k
+8,994
52.7%
69
TALKSPACE INC
COM
TALK
TALK
105,252
$547.3k0.52%
0.52%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 175.6k, Q2 2026 105.3k
-70.3k
-70,299
-40.0%
70
NVIDIA CORPORATION
COM
NVDA
NVDA
2,735
$547.2k0.52%
0.52%
New Shares held: Q3 2025 —, Q4 2025 6.3k, Q1 2026 0, Q2 2026 2.7k
71
UROGEN PHARMA LTD
COM
URGN
URGN
14,440
$531.4k0.51%
0.51%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 14.4k
72
ATAIBECKLEY INC
COM SHS
ATAI
ATAI
100,681
$530.6k0.51%
0.51%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 227.7k, Q2 2026 100.7k
-127.0k
-126,989
-55.8%
73
CALIFORNIA RES CORP
COM STOCK
CRC
CRC
10,000
$528.7k0.51%
0.51%
Reduced Shares held: Q3 2025 —, Q4 2025 7.2k, Q1 2026 22.5k, Q2 2026 10.0k
-12.5k
-12,500
-55.6%
74
CULLINAN THERAPEUTICS INC
COM
CGEM
CGEM
28,987
$527.9k0.51%
0.51%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 12.6k, Q2 2026 29.0k
+16.4k
+16,383
130.0%
75
IBIO INC
COM NEW
IBIO
IBIO
298,927
$523.1k0.50%
0.50%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 56.3k, Q2 2026 298.9k
+242.6k
+242,609
430.8%
76
VIATRIS INC
COM
VTRS
VTRS
32,500
$516.1k0.49%
0.49%
Unchanged Shares held: Q3 2025 —, Q4 2025 65.0k, Q1 2026 32.5k, Q2 2026 32.5k
77
INNOVAGE HLDG CORP
COM
INNV
INNV
42,139
$499.3k0.48%
0.48%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 31.6k, Q2 2026 42.1k
+10.5k
+10,498
33.2%
78
HELLO GROUP INC
ADS
MOMO
MOMO
84,685
$491.2k0.47%
0.47%
Reduced Shares held: Q3 2025 —, Q4 2025 109.2k, Q1 2026 149.3k, Q2 2026 84.7k
-64.6k
-64,568
-43.3%
79
PMV PHARMACEUTICALS INC
COM
PMVP
PMVP
362,361
$485.6k0.47%
0.47%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 180.2k, Q2 2026 362.4k
+182.2k
+182,200
101.1%
80
NATIONAL HEALTHCARE CORP
COM
NHC
NHC
2,295
$485.1k0.46%
0.46%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 2.3k
81
CIRRUS LOGIC INC
COM
CRUS
CRUS
3,265
$484.9k0.46%
0.46%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 3.2k, Q2 2026 3.3k
+28
+28
0.9%
82
MICRON TECHNOLOGY INC
COM
MU
MU
419
$483.6k0.46%
0.46%
Reduced Shares held: Q3 2025 —, Q4 2025 6.8k, Q1 2026 3.8k, Q2 2026 419
-3.4k
-3,422
-89.1%
83
JONES LANG LASALLE INC
COM
JLL
JLL
1,552
$481.0k0.46%
0.46%
Reduced Shares held: Q3 2025 —, Q4 2025 690, Q1 2026 3.2k, Q2 2026 1.6k
-1.6k
-1,611
-50.9%
84
APA CORPORATION
COM
APA
APA
14,562
$474.3k0.45%
0.45%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 14.6k
85
RMR GROUP INC
CL A
RMR
RMR
22,496
$461.8k0.44%
0.44%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 22.5k
86
FULCRUM THERAPEUTICS INC
COM
FULC
FULC
125,224
$458.3k0.44%
0.44%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 125.2k
87
PROG HOLDINGS INC
COM NPV
PRG
PRG
9,382
$437.3k0.42%
0.42%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 22.3k, Q2 2026 9.4k
-12.9k
-12,917
-57.9%
88
SEPTERNA INC
COM
SEPN
SEPN
12,970
$434.4k0.42%
0.42%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 13.0k
89
BIOAGE LABS INC
COM
BIOA
BIOA
17,394
$426.3k0.41%
0.41%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 15.2k, Q2 2026 17.4k
+2.2k
+2,184
14.4%
90
TERADYNE INC
COM
TER
TER
878
$424.8k0.41%
0.41%
Reduced Shares held: Q3 2025 —, Q4 2025 1.0k, Q1 2026 2.0k, Q2 2026 878
-1.1k
-1,138
-56.5%
91
ARROW ELECTRS INC
COM
ARW
ARW
1,976
$421.7k0.40%
0.40%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 2.3k, Q2 2026 2.0k
-344
-344
-14.8%
92
INGLES MKTS INC
CL A
IMKTA
IMKTA
4,734
$419.3k0.40%
0.40%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 4.7k
93
ERASCA INC
COM
ERAS
ERAS
22,460
$411.5k0.39%
0.39%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 33.1k, Q2 2026 22.5k
-10.6k
-10,610
-32.1%
94
VIANT TECHNOLOGY INC
COM CL A
DSP
DSP
31,880
$403.6k0.39%
0.39%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 31.9k
95
QUALCOMM INC
COM
QCOM
QCOM
2,161
$399.3k0.38%
0.38%
New Shares held: Q3 2025 —, Q4 2025 7.0k, Q1 2026 0, Q2 2026 2.2k
96
SHATTUCK LABS INC
COM
STTK
STTK
57,231
$397.2k0.38%
0.38%
Added Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 13.4k, Q2 2026 57.2k
+43.9k
+43,853
327.8%
97
ZURA BIO LTD
CLASS A ORD SHS
ZURA
ZURA
66,919
$394.8k0.38%
0.38%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 97.1k, Q2 2026 66.9k
-30.2k
-30,183
-31.1%
98
LAM RESEARCH CORP
COM NEW
LRCX
LRCX
893
$387.0k0.37%
0.37%
Reduced Shares held: Q3 2025 —, Q4 2025 15.5k, Q1 2026 5.2k, Q2 2026 893
-4.3k
-4,270
-82.7%
99
SAVARA INC
COM
SVRA
SVRA
61,759
$380.4k0.36%
0.36%
Reduced Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 128.4k, Q2 2026 61.8k
-66.6k
-66,617
-51.9%
100
MAZE THERAPEUTICS INC
COM
MAZE
MAZE
12,618
$376.5k0.36%
0.36%
New Shares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 12.6k